证券记录 · 已归档季度
IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
12被追踪持有人
—Δ持有人
17.55M持有股份
$114.44M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -4 | 110.50M | $465.13M | +4 | −8 |
| Q1 2026 | 94 | +9 | 125.58M | $394.14M | +11 | −2 |
| Q4 2025 | 85 | +2 | 100.81M | $339.86M | +2 | — |
| Q3 2025 | 17 | 0 | 58.02M | $76.00M | — | — |
| Q2 2025 | 14 | 0 | 58.90M | $42.25M | +1 | −1 |
| Q1 2025 | 11 | 0 | 30.28M | $44.51M | +1 | −1 |
| Q4 2024 | 11 | 0 | 26.27M | $116.38M | +1 | −1 |
| Q3 2024 | 10 | -2 | 15.74M | $64.83M | — | −2 |
| Q2 2024 | 12 | — | 17.55M | $114.44M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 8.57M | — | $55.89M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 3.37M | — | $21.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 3.37M | — | $21.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (被动) | 1.39M | — | $9.08M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.33M | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.33M | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 917.59K | — | $5.98M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 684.58K | — | $4.46M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 684.58K | — | $4.46M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 684.58K | — | $4.46M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 409.53K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 409.53K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 384.95K | — | $2.51M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 384.95K | — | $2.51M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 217.22K | — | $1.42M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 109.50K | — | $713,907 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 109.50K | — | $713,907 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 109.50K | — | $713,907 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 109.50K | — | $713,907 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 101.45K | — | $662,000 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 60.16K | — | $392,243 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 222 持有人, 159.91M 股份, $533.78M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据